Advances in Protein Chemistry and Structural Biology - 1st Edition - ISBN: 9780123864833, 9780123864840

Advances in Protein Chemistry and Structural Biology, Volume 84

1st Edition

Serial Volume Editors: Rossen Donev
eBook ISBN: 9780123864840
Hardcover ISBN: 9780123864833
Imprint: Academic Press
Published Date: 29th August 2011
Page Count: 216
Sales tax will be calculated at check-out Price includes VAT/GST
126.00
88.20
88.20
88.20
100.80
88.20
88.20
100.80
101.00
70.70
70.70
70.70
80.80
70.70
70.70
80.80
166.00
116.20
116.20
116.20
132.80
116.20
116.20
132.80
161.00
112.70
112.70
112.70
128.80
112.70
112.70
128.80
Unavailable
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

Nucleic acid-mediated protein aggregation and assembly

I. Introduction

II. Nucleic Acid-Mediated Aggregation of Amyloid Proteins

III. Nucleic Acid Sequestration to Pathological Tissues

IV. Self-Assembly of Protein Nanostructures in the Presence of Nucleic Acids

V. Summary

Aggregation, stability, and formulation of human antibody therapeutics

I. Introduction

II. Expression of Human Monoclonal Antibodies and Antibody Fragments

III. Methods for Analyzing Solubility, Aggregation and Stability of Monoclonal Antibodies

IV. Addressing Aggregation and Increasing Stability of Monoclonal Antibodies

Lysozyme

I. Introduction

II. Amyloid and Amyloidosis

III. Human Lysozyme

IV. Aggregation of Hen Lysozyme In Vitro

V. Recovery and Purification of Lysozyme from Inclusion Bodies

VI. Inhibition of Lysozyme Aggregation

VII. Future Perspectives

Protein aggregation in a membrane environment

I. Introduction

II. The Role of Electrostatics in Membrane-Mediated Protein Aggregation

III. Hydrophobic Effect as Driving Force for Protein Aggregation

IV. Hydrogen-Bonding as Determinant of Protein Aggregation Propensity

V. Experimental Techniques Used to Study Protein Aggregation

VI. Concluding Remarks

Contactins

I. Introduction

II. Genetic Implication of CNTN4, CNTN5, and CNTN6 in Neurodevelopment

III. Expression of Contactins During Brain Development

IV. Phenotypes in Contactin Null-Mutants

V. Structural Architecture of Contactins

VI. Protein–Protein Interactions Mediated by Contactins

VII. Final Remarks

Author Index

Subject Index


Description

Published continuously since 1944, the Advances in Protein Chemistry and Structural Biology serial has been a continuous, essential resource for protein chemists. Covering reviews of methodology and research in all aspects of protein chemistry, including purification/expression, proteomics, modeling and structural determination and design, each volume brings forth new information about protocols and analysis of proteins while presenting the most recent findings from leading experts in a broad range of protein-related topics. This volume features articles on Protein Aggregation.

Key Features

  • Covers reviews of methodology and research in all aspects of protein chemistry
  • Brings forth new information about protocols and analysis of proteins while presenting the most recent findings from leading experts in a broad range of protein-related topics

Readership

Biochemists, biophysicists, cell biologists, protein chemists, structural geneticists, and structural biologists


Details

No. of pages:
216
Language:
English
Copyright:
© Academic Press 2011
Published:
Imprint:
Academic Press
eBook ISBN:
9780123864840
Hardcover ISBN:
9780123864833

Reviews

"The authority, originality, and editing of the reviews are first class." --Nature

Ratings and Reviews


About the Serial Volume Editors

Rossen Donev Serial Volume Editor

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2010 Dr. Donev was appointed Senior Lecturer in Swansea University. Currently he is Head of Research at MicroPharm Ltd, UK and Director of Biomed Consult, UK. He has published more than 60 research papers, has chaired scientific meetings in Molecular Medicine and given plenary talks. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and development of therapeutic strategies for their treatment. More recently he has focused on design of antibody-based oral treatment of pathological conditions of the colon and small intestines.

Affiliations and Expertise

Swansea University, UK